更正：miR-22在造血中的双面性：它是一种致癌肿瘤抑制因子还是一种抑瘤癌基因？

IF 3.9 2区生物学 Q1 GENETICS & HEREDITY

PLoS Genetics Pub Date : 2026-08-25 eCollection Date: 2026-08-01 DOI:10.1371/journal.pgen.1012281

引用次数: 0

摘要

[此更正文章DOI: 10.1371/journal.pgen.1006505.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene?

[This corrects the article DOI: 10.1371/journal.pgen.1006505.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

PLoS Genetics GENETICS & HEREDITY-

自引率

2.20%

发文量

438

期刊介绍： PLOS Genetics is run by an international Editorial Board, headed by the Editors-in-Chief, Greg Barsh (HudsonAlpha Institute of Biotechnology, and Stanford University School of Medicine) and Greg Copenhaver (The University of North Carolina at Chapel Hill). Articles published in PLOS Genetics are archived in PubMed Central and cited in PubMed.